Physician profile
Nelson J Mar
NPI 1851447601
$2,056.29
in general payments reported to CMS, 2019-2025
11 companies · $16.77 in 2025
The $16.77 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,276 · 2020: $383 · 2021: $187 · 2022: $34.27 · 2023: $20.13 · 2024: $139 · 2025: $16.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123 · Education: $52.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.33 |
| Education | $52.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $1,640.00 | 2019-2021 | |
| Dentsply Sirona INC | $158.84 | 2019-2023 | Primescan Connect |
| Solventum Corporation | $70.05 | 2024 | 3m Filtek, Filtek |
| Colgate Oral Pharmaceuticals, INC. | $52.44 | 2024 | |
| Dentsply Ih INC. | $23.89 | 2019 | |
| Biohorizons Implant Systems INC. | $22.73 | 2020 | |
| Kerr Corporation | $20.83 | 2021 | |
| 3m Company | $17.97 | 2022 | |
| Envista Holdings Corporation | $16.77 | 2025 | Spark |
| Align Technology, INC. | $16.39 | 2021 | |
| Gc America INC. | $16.38 | 2024 | G-Premio Bond, G-Aenial, G-Aenial |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Mar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.